Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Runge

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Circulation|February 1, 1989
Plasminogen activators. The old and the newM S Runge, T Quertermous, E Haber
Journal of Vascular and Interventional Radiology : JVIR|November 1, 1995
The promise of new genetically engineered plasminogen activatorsD Cutler, C Bode, M S Runge
The Year in Immunology|January 1, 1989
Improving on nature: antibody-targeted enzymesC Bode, M S Runge, E Haber
Bioconjugate Chemistry|July 1, 1992
Purifying antibody-plasminogen activator conjugatesC Bode, M S Runge, E Haber
Clinical Cardiology|June 1, 1990
Future directions in plasminogen activator therapyC Bode, M S Runge, E Haber
Circulation Research|January 11, 2000
The oxidative paradox: another piece in the puzzleC Patterson, N R Madamanchi, M S Runge
The Journal of Biological Chemistry|March 15, 1993
The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activatorI M Lubin, R Caban, M S Runge
Methods in Molecular Medicine|February 19, 2011
In situ hybridizationS R Runge, Z Hu, M S Runge
Gene|August 15, 1992
A rat beta-interferon-induced mRNA: sequence characterizationD J Hayzer, E Brinson, M S Runge
Circulation Research|April 3, 1999
Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factorsY Han, M S Runge, A R Brasier
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Circulation|February 1, 1989
Plasminogen activators. The old and the newM S Runge, T Quertermous, E Haber
Journal of Vascular and Interventional Radiology : JVIR|November 1, 1995
The promise of new genetically engineered plasminogen activatorsD Cutler, C Bode, M S Runge
The Year in Immunology|January 1, 1989
Improving on nature: antibody-targeted enzymesC Bode, M S Runge, E Haber
Bioconjugate Chemistry|July 1, 1992
Purifying antibody-plasminogen activator conjugatesC Bode, M S Runge, E Haber
Clinical Cardiology|June 1, 1990
Future directions in plasminogen activator therapyC Bode, M S Runge, E Haber
Circulation Research|January 11, 2000
The oxidative paradox: another piece in the puzzleC Patterson, N R Madamanchi, M S Runge
The Journal of Biological Chemistry|March 15, 1993
The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activatorI M Lubin, R Caban, M S Runge
Methods in Molecular Medicine|February 19, 2011
In situ hybridizationS R Runge, Z Hu, M S Runge
Gene|August 15, 1992
A rat beta-interferon-induced mRNA: sequence characterizationD J Hayzer, E Brinson, M S Runge
Circulation Research|April 3, 1999
Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factorsY Han, M S Runge, A R Brasier
Pageof 14